Difficult-to-treat gout flares eligibility for interleukin-1 inhibition in private practice is uncommon according to current EMA approval - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Rheumatology Année : 2019

Difficult-to-treat gout flares eligibility for interleukin-1 inhibition in private practice is uncommon according to current EMA approval

Fichier non déposé

Dates et versions

hal-02179667 , version 1 (11-07-2019)

Identifiants

Citer

Tristan Pascart, Laurène Norberciak, Hang-Korng Ea, Sahara Graf, Pascal Guggenbuhl, et al.. Difficult-to-treat gout flares eligibility for interleukin-1 inhibition in private practice is uncommon according to current EMA approval. Rheumatology, 2019, 58 (12), pp.2181-2187. ⟨10.1093/rheumatology/kez203⟩. ⟨hal-02179667⟩
27 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More